Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1998;6(4):191–194. doi: 10.1002/(SICI)1098-0997(1998)6:4<191::AID-IDOG10>3.0.CO;2-6

Boric acid vaginal suppositories: a brief review.

S M Prutting 1, J D Cerveny 1
PMCID: PMC1784796  PMID: 9812253

Full Text

The Full Text of this article is available as a PDF (373.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chaim W. Fungal vaginitis caused by nonalbicans species. Am J Obstet Gynecol. 1997 Aug;177(2):485–486. doi: 10.1016/s0002-9378(97)70237-0. [DOI] [PubMed] [Google Scholar]
  2. Fayinka O. A. Boric acid--a useful preservative for urine samples. Afr J Med Sci. 1971 Oct;2(4):377–385. [PubMed] [Google Scholar]
  3. Jansen J. A., Andersen J., Schou J. S. Boric acid single dose pharmacokinetics after intravenous administration to man. Arch Toxicol. 1984 Mar;55(1):64–67. doi: 10.1007/BF00316588. [DOI] [PubMed] [Google Scholar]
  4. Jovanovic R., Congema E., Nguyen H. T. Antifungal agents vs. boric acid for treating chronic mycotic vulvovaginitis. J Reprod Med. 1991 Aug;36(8):593–597. [PubMed] [Google Scholar]
  5. Nyirjesy P., Seeney S. M., Grody M. H., Jordan C. A., Buckley H. R. Chronic fungal vaginitis: the value of cultures. Am J Obstet Gynecol. 1995 Sep;173(3 Pt 1):820–823. doi: 10.1016/0002-9378(95)90347-x. [DOI] [PubMed] [Google Scholar]
  6. Porter I. A., Brodie J. Boric acid preservation of urine samples. Br Med J. 1969 May 10;2(5653):353–355. doi: 10.1136/bmj.2.5653.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Redondo-Lopez V., Lynch M., Schmitt C., Cook R., Sobel J. D. Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents. Obstet Gynecol. 1990 Oct;76(4):651–655. [PubMed] [Google Scholar]
  8. Schillinger B. M., Berstein M., Goldberg L. A., Shalita A. R. Boric acid poisoning. J Am Acad Dermatol. 1982 Nov;7(5):667–673. doi: 10.1016/s0190-9622(82)70149-5. [DOI] [PubMed] [Google Scholar]
  9. Shinohara Y. T., Tasker S. A. Successful use of boric acid to control azole-refractory Candida vaginitis in a woman with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Nov 1;16(3):219–220. doi: 10.1097/00042560-199711010-00013. [DOI] [PubMed] [Google Scholar]
  10. Shubair M., Larsen B. Growth inhibition of Candida albicans and other medically important yeasts by vaginal contraceptive products. Gynecol Obstet Invest. 1990;29(1):67–70. doi: 10.1159/000293303. [DOI] [PubMed] [Google Scholar]
  11. Siegel E., Wason S. Boric acid toxicity. Pediatr Clin North Am. 1986 Apr;33(2):363–367. doi: 10.1016/s0031-3955(16)35006-4. [DOI] [PubMed] [Google Scholar]
  12. Skinner G. R., Hartley C. E., Millar D., Bishop E. Possible treatment for cold sores. Br Med J. 1979 Sep 22;2(6192):704–704. doi: 10.1136/bmj.2.6192.704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sobel J. D., Chaim W. Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy. Clin Infect Dis. 1997 Apr;24(4):649–652. doi: 10.1093/clind/24.4.649. [DOI] [PubMed] [Google Scholar]
  14. Sobel J. D. Vaginitis. N Engl J Med. 1997 Dec 25;337(26):1896–1903. doi: 10.1056/NEJM199712253372607. [DOI] [PubMed] [Google Scholar]
  15. Sobel J. D., Vazquez J. A. Symptomatic vulvovaginitis due to fluconazole-resistant Candida albicans in a female who was not infected with human immunodeficiency virus. Clin Infect Dis. 1996 Apr;22(4):726–727. doi: 10.1093/clinids/22.4.726. [DOI] [PubMed] [Google Scholar]
  16. Sobel J. D., Vazquez J., Lynch M., Meriwether C., Zervos M. J. Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects, and therapy. Clin Infect Dis. 1993 Jan;16(1):93–99. doi: 10.1093/clinids/16.1.93. [DOI] [PubMed] [Google Scholar]
  17. Spinillo A., Capuzzo E., Gulminetti R., Marone P., Colonna L., Piazzi G. Prevalence of and risk factors for fungal vaginitis caused by non-albicans species. Am J Obstet Gynecol. 1997 Jan;176(1 Pt 1):138–141. doi: 10.1016/s0002-9378(97)80026-9. [DOI] [PubMed] [Google Scholar]
  18. Swate T. E., Weed J. C. Boric acid treatment of vulvovaginal candidiasis. Obstet Gynecol. 1974 Jun;43(6):893–895. [PubMed] [Google Scholar]
  19. Thai L., Hart L. L. Boric acid vaginal suppositories. Ann Pharmacother. 1993 Nov;27(11):1355–1357. [PubMed] [Google Scholar]
  20. Van Slyke K. K., Michel V. P., Rein M. F. The boric acid powder treatment of vulvovaginal candidiasis. J Am Coll Health Assoc. 1981 Dec;30(3):107–109. doi: 10.1080/01644300.1981.10393050. [DOI] [PubMed] [Google Scholar]
  21. Van Slyke K. K., Michel V. P., Rein M. F. Treatment of vulvovaginal candidiasis with boric acid powder. Am J Obstet Gynecol. 1981 Sep 15;141(2):145–148. doi: 10.1016/s0002-9378(16)32581-9. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES